CAPD--a risk factor in renal transplantation?

Area of Science:

• Nephrology
• Immunology
• Transplantation

Background:

• Theoretical concerns suggest potential disparities in renal transplant outcomes between patients on continuous ambulatory peritoneal dialysis (CAPD) and those on hemodialysis (HD).
• Previous studies have not definitively established the comparative success rates of renal allografts in these distinct patient populations.

Purpose of the Study:

• To investigate and compare the graft survival rates of cadaveric renal allografts in patients treated with CAPD versus HD.
• To explore potential immunological factors contributing to any observed differences in transplant outcomes.

Main Methods:

• Retrospective review of 121 consecutive cadaveric renal allografts.
• Comparison of graft survival rates between CAPD and HD patient groups at one year post-transplantation.
• Analysis of T cell subsets using monoclonal antibodies to assess immune status.

Main Results:

• Graft survival rates at one year were significantly lower in the CAPD group (35.5%) compared to the HD group (63.5%).
• The observed difference in graft survival was independent of dialysis duration.
• A significant blood transfusion effect on graft survival was noted in the HD group but not in the CAPD group.
• Differences in T cell subsets suggest a role for immune integrity in explaining the outcome disparities.

Conclusions:

• Continuous ambulatory peritoneal dialysis (CAPD) is associated with poorer renal transplant graft survival compared to hemodialysis (HD).
• Preserved or restored immunological integrity in CAPD patients may partially explain these differing outcomes.
• Further research into the immunological mechanisms is warranted to improve transplant success in CAPD patients.